Clinical significance of chronic pulmonary aspergillosis in lung cancer patients undergoing anticancer drug therapy

Abstract Background Advances in anticancer drugs for lung cancer (LC) have improved the prognosis of LC. Chronic pulmonary aspergillosis (CPA) is a progressive and often exacerbating respiratory disease with a poor prognosis. To date, the prognosis of LC complicated by CPA has not been elucidated. T...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Kenji Morimoto, Ryosuke Hamashima, Tadaaki Yamada, Toshihide Yokoyama, Takehiko Kobayashi, Kazunari Tsuyuguchi, Takanori Kanematsu, Nobuyo Tamiya, Taisuke Tsuji, Ryota Nakamura, Yuki Katayama, Naoya Nishioka, Masahiro Iwasaku, Shinsaku Tokuda, Koichi Takayama
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Wiley 2024-09-01
Serie:	Thoracic Cancer
Soggetti:	chronic pulmonary aspergillosis lung cancer prognosis safety
Accesso online:	https://doi.org/10.1111/1759-7714.15416
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!